Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Mesothelial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00571298
What this trial is testing

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Brigham and Women's Hospital 141
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Early research (Phase 1)Ended earlyNCT01258868
What this trial is testing

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Who this might be right for
MesoltheliomaEsophageal CancerLung Cancer+2 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Testing effectiveness (Phase 2)Study completedNCT02303899
What this trial is testing

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

Who this might be right for
Mesothelioma, Malignant
Istituto Clinico Humanitas 22
Large-scale testing (Phase 3)Ended earlyNCT04158141
What this trial is testing

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Epithelioid MesotheliomaStage I Pleural Malignant Mesothelioma AJCC v8+4 more
NRG Oncology 16
Testing effectiveness (Phase 2)UnknownNCT00996385
What this trial is testing

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Columbia University 29
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Large-scale testing (Phase 3)Study completedNCT00005636
What this trial is testing

Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02293005
What this trial is testing

Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Who this might be right for
Lung CancerMesothelioma
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT04400539
What this trial is testing

The IMmunotherapy Pleural 5-ALA PDT

Who this might be right for
Mesotheliomas PleuralMalignant Pleural Mesothelioma
University Hospital, Lille 20
Testing effectiveness (Phase 2)UnknownNCT04013334
What this trial is testing

MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Momotaro-Gene Inc. 12
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Not applicableUnknownNCT05508555
What this trial is testing

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaChemotherapy Effect
Ain Shams University 50
Not applicableStudy completedNCT04775446
What this trial is testing

Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy

Who this might be right for
Malignant Pleural Mesothelioma
Centre Hospitalier Intercommunal Creteil 116
Early research (Phase 1)Study completedNCT00280982
What this trial is testing

Dendritic Cell-based Immunotherapy in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Early research (Phase 1)Active Not RecruitingNCT03546426
What this trial is testing

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Who this might be right for
Mesothelioma, MalignantPD-L1 NegativeAdvanced Cancer+1 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Not applicableUnknownNCT02761863
What this trial is testing

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 100
Next Page